These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1028 related items for PubMed ID: 18546285

  • 1. Botulinum toxin type A induces direct analgesic effects in chronic neuropathic pain.
    Ranoux D, Attal N, Morain F, Bouhassira D.
    Ann Neurol; 2008 Sep; 64(3):274-83. PubMed ID: 18546285
    [Abstract] [Full Text] [Related]

  • 2. The effect of venlafaxine on ongoing and experimentally induced pain in neuropathic pain patients: a double blind, placebo controlled study.
    Yucel A, Ozyalcin S, Koknel Talu G, Kiziltan E, Yucel B, Andersen OK, Arendt-Nielsen L, Disci R.
    Eur J Pain; 2005 Aug; 9(4):407-16. PubMed ID: 15979021
    [Abstract] [Full Text] [Related]

  • 3. Fentanyl buccal tablet for the relief of breakthrough pain in opioid-tolerant adult patients with chronic neuropathic pain: a multicenter, randomized, double-blind, placebo-controlled study.
    Simpson DM, Messina J, Xie F, Hale M.
    Clin Ther; 2007 Apr; 29(4):588-601. PubMed ID: 17617282
    [Abstract] [Full Text] [Related]

  • 4. The efficacy of the AMPA receptor antagonist NS1209 and lidocaine in nerve injury pain: a randomized, double-blind, placebo-controlled, three-way crossover study.
    Gormsen L, Finnerup NB, Almqvist PM, Jensen TS.
    Anesth Analg; 2009 Apr; 108(4):1311-9. PubMed ID: 19299805
    [Abstract] [Full Text] [Related]

  • 5. Botulinum toxin type-A (BOTOX) in the treatment of occipital neuralgia: a pilot study.
    Taylor M, Silva S, Cottrell C.
    Headache; 2008 Apr; 48(10):1476-81. PubMed ID: 19076646
    [Abstract] [Full Text] [Related]

  • 6. Botulinum toxin a in the treatment of chronic tension-type headache with cervical myofascial trigger points: a randomized, double-blind, placebo-controlled pilot study.
    Harden RN, Cottrill J, Gagnon CM, Smitherman TA, Weinland SR, Tann B, Joseph P, Lee TS, Houle TT.
    Headache; 2009 May; 49(5):732-43. PubMed ID: 19178577
    [Abstract] [Full Text] [Related]

  • 7. Mirtazapine decreases the pain feeling in healthy participants.
    Arnold P, Vuadens P, Kuntzer T, Gobelet C, Deriaz O.
    Clin J Pain; 2008 Feb; 24(2):116-9. PubMed ID: 18209516
    [Abstract] [Full Text] [Related]

  • 8. Botulinum toxin A does not alter capsaicin-induced pain perception in human skin.
    Schulte-Mattler WJ, Opatz O, Blersch W, May A, Bigalke H, Wohlfahrt K.
    J Neurol Sci; 2007 Sep 15; 260(1-2):38-42. PubMed ID: 17481662
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Efficacy and safety of a single botulinum type A toxin complex treatment (Dysport) for the relief of upper back myofascial pain syndrome: results from a randomized double-blind placebo-controlled multicentre study.
    Göbel H, Heinze A, Reichel G, Hefter H, Benecke R, Dysport myofascial pain study group.
    Pain; 2006 Nov 15; 125(1-2):82-8. PubMed ID: 16750294
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Central pituitary adenylate cyclase 1 receptors modulate nociceptive behaviors in both inflammatory and neuropathic pain states.
    Davis-Taber R, Baker S, Lehto SG, Zhong C, Surowy CS, Faltynek CR, Scott VE, Honore P.
    J Pain; 2008 May 15; 9(5):449-56. PubMed ID: 18337184
    [Abstract] [Full Text] [Related]

  • 17. Botulinum toxin for diabetic neuropathic pain: a randomized double-blind crossover trial.
    Yuan RY, Sheu JJ, Yu JM, Chen WT, Tseng IJ, Chang HH, Hu CJ.
    Neurology; 2009 Apr 28; 72(17):1473-8. PubMed ID: 19246421
    [Abstract] [Full Text] [Related]

  • 18. Local application of capsaicin alleviates mechanical hyperalgesia after spinal nerve transection.
    Kim SM, Kim J, Kim E, Hwang SJ, Shin HK, Lee SE.
    Neurosci Lett; 2008 Mar 15; 433(3):199-204. PubMed ID: 18242851
    [Abstract] [Full Text] [Related]

  • 19. A double-blind, controlled study of botulinum toxin A in chronic myofascial pain.
    Qerama E, Fuglsang-Frederiksen A, Kasch H, Bach FW, Jensen TS.
    Neurology; 2006 Jul 25; 67(2):241-5. PubMed ID: 16864815
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 52.